Publications by authors named "E M Bruening"

The equilibrium structure of the RNA sugar-phosphate backbone and its hydration shell is distinctly different from hydrated DNA. Applying femtosecond two-dimensional infrared (2D-IR) spectroscopy in a range from 950 to 1300 cm, we elucidate the character, dynamics, and couplings of backbone modes of a double-stranded RNA A-helix geometry in its aqueous environment. The 2D-IR spectra display a greater number of backbone modes than for DNA, with distinctly different lineshapes of diagonal peaks.

View Article and Find Full Text PDF
Article Synopsis
  • Current methods for genetic engineering of cytomegalovirus (CMV) are inefficient, leading to mutations and difficulties in manipulating multiple genome locations simultaneously due to the use of bacterial artificial chromosomes (BACs).
  • The researchers adapted synthetic biology tools to clone the entire CMV genome by using transformation-associated recombination (TAR), successfully reconstituting the parental strain from overlapping fragments in yeast.
  • This new strategy not only allows for more efficient genome manipulation of CMV but also facilitates the creation of viral genomes derived from synthetic DNA, improving the experimental capabilities in studying large DNA viruses.
View Article and Find Full Text PDF

Unlabelled: Formalin fixation and paraffin embedding present the standard procedures for conserving clinical tissues for histological analysis. However, molecular analysis is impaired by the cross linking properties of formalin. The PAXgene tissue system (PreAnalytix, Switzerland) is a new formalin-free tissue collection device.

View Article and Find Full Text PDF

Expression profiling of clinically obtainable tumor specimens has been hindered by the need for microgram quantities of RNA. In vitro transcription (IVT)-based amplifications are most commonly used to amplify small quantities of RNA for microarray analysis. However, significant drawbacks exist with IVT-based amplification, and the need for alternative amplification methods remains.

View Article and Find Full Text PDF

Human cytomegalovirus (HCMV) is a major opportunistic pathogen in immunocompromised individuals. Current therapies target viral DNA replication and accumulate mutations that yield cross-resistance among the approved drugs. A novel, non-nucleoside inhibitor of HCMV replication, PD0084430, was identified in a screening assay using the HCMV beta-galactosidase recombinant RC256.

View Article and Find Full Text PDF